From the Department of Pharmacology, Institute of Chinese Integrative Medicine, Hebei Medical University, Shijiazhuang, China (Y.X., N.Z., W.Z., L.-M.R.); and the Department of Pharmacy, Hebei North University, Zhangjiakou, China (N.Z.).
Anesthesiology. 2018 Mar;128(3):539-554. doi: 10.1097/ALN.0000000000002003.
Bupivacaine induces central neurotoxicity at lower blood concentrations than cardiovascular toxicity. However, central sensitivity to bupivacaine is poorly understood. The toxicity mechanism might be related to glutamate-induced excitotoxicity in hippocampal cells.
The intracellular free Ca concentration ([Ca]i), mitochondrial membrane potential, and reactive oxygen species generation were measured by fluorescence and two-photon laser scanning microscopy in fetal rat hippocampal neurons and astrocytes.
In astrocyte/neuron cocultures, 300 μM bupivacaine inhibited glutamate-induced increases in [Ca]i in astrocytes by 40% (P < 0.0001; n = 20) but significantly potentiated glutamate-induced increases in [Ca]i in neurons by 102% (P = 0.0007; n = 10). Ropivacaine produced concentration-dependent effects similar to bupivacaine (0.3 to 300 μM). Tetrodotoxin did not mimic bupivacaine's effects. In pure cell cultures, bupivacaine did not affect glutamate-induced increases in [Ca]i in neurons but did inhibit increased [Ca]i in astrocytes. Moreover, bupivacaine produced a 61% decrease in the mitochondrial membrane potential (n = 20) and a 130% increase in reactive oxygen species generation (n = 15) in astrocytes. Cyclosporin A treatment suppressed bupivacaine's effects on [Ca]i, mitochondrial membrane potential, and reactive oxygen species generation. When astrocyte/neuron cocultures were incubated with 500 μM dihydrokainic acid (a specific glutamate transporter-1 inhibitor), bupivacaine did not potentiate glutamate-induced increases in [Ca]i in neurons but still inhibited glutamate-induced increases in [Ca]i in astrocytes.
In primary rat hippocampal astrocyte and neuron cocultures, clinically relevant concentrations of bupivacaine selectively impair astrocytic mitochondrial function, thereby suppressing glutamate uptake, which indirectly potentiates glutamate-induced increases in [Ca]i in neurons.
布比卡因在引起心血管毒性的血药浓度以下即可引起中枢神经毒性。然而,人们对布比卡因的中枢敏感性知之甚少。其毒性机制可能与海马细胞中谷氨酸诱导的兴奋性毒性有关。
通过荧光和双光子激光扫描显微镜测量胎鼠海马神经元和星形胶质细胞的细胞内游离钙浓度([Ca]i)、线粒体膜电位和活性氧的产生。
在星形胶质细胞/神经元共培养物中,300μM 布比卡因抑制星形胶质细胞中谷氨酸诱导的[Ca]i 增加 40%(P<0.0001;n=20),但显著增强神经元中谷氨酸诱导的[Ca]i 增加 102%(P=0.0007;n=10)。罗哌卡因产生浓度依赖性效应,类似于布比卡因(0.3-300μM)。河豚毒素不能模拟布比卡因的作用。在纯细胞培养物中,布比卡因不影响神经元中谷氨酸诱导的[Ca]i 增加,但抑制星形胶质细胞中[Ca]i 的增加。此外,布比卡因使星形胶质细胞的线粒体膜电位降低 61%(n=20),活性氧生成增加 130%(n=15)。环孢菌素 A 处理抑制了布比卡因对[Ca]i、线粒体膜电位和活性氧生成的作用。当星形胶质细胞/神经元共培养物用 500μM 二氢酮酸(一种特定的谷氨酸转运体-1 抑制剂)孵育时,布比卡因不会增强谷氨酸诱导的神经元[Ca]i 增加,但仍抑制星形胶质细胞中谷氨酸诱导的[Ca]i 增加。
在原代大鼠海马星形胶质细胞和神经元共培养物中,临床相关浓度的布比卡因选择性损害星形胶质细胞的线粒体功能,从而抑制谷氨酸摄取,这间接增强了神经元中谷氨酸诱导的[Ca]i 增加。